GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Other Current Liabilities

Yumanity Therapeutics (FRA:8IY) Other Current Liabilities : €0.25 Mil (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Other Current Liabilities?

Yumanity Therapeutics's other current liabilities for the quarter that ended in Sep. 2022 was €0.25 Mil.

Yumanity Therapeutics's quarterly other current liabilities declined from Mar. 2022 (€1.04 Mil) to Jun. 2022 (€0.68 Mil) and declined from Jun. 2022 (€0.68 Mil) to Sep. 2022 (€0.25 Mil).

Yumanity Therapeutics's annual other current liabilities increased from Dec. 2019 (€1.19 Mil) to Dec. 2020 (€3.53 Mil) but then declined from Dec. 2020 (€3.53 Mil) to Dec. 2021 (€1.56 Mil).


Yumanity Therapeutics Other Current Liabilities Historical Data

The historical data trend for Yumanity Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Other Current Liabilities Chart

Yumanity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21
Other Current Liabilities
- - -

Yumanity Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Yumanity Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Yumanity Therapeutics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Yumanity Therapeutics (FRA:8IY) Business Description

Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines